首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line
【24h】

Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line

机译:使用基于壳聚糖的纳米颗粒共同递送胰岛素样生长因子1受体特异性siRNA和阿霉素可增强A549肺癌细胞系的抗癌功效

获取原文
获取外文期刊封面目录资料

摘要

Here, we investigated the effects of dual delivery of IGF-1R siRNA and doxorubicin by chitosan nanoparticles on viability of A549 lung cancer cells line by utilization of MTT and qRT-PCR. Furthermore apoptosis and migration of treated cells were assessed by Annexin-PI and wound healing assays, respectively. The chitosan nanoparticles had about 176 nm size with zeta potential and polydispersive index about 11 mV and 0.3, respectively. The IGF-1R siRNA had synergistic effect on DOX-induced cytotoxicity and apoptosis in tumour cells. In addition, siRNA/DOX-loaded chitosan nanoparticles could significantly decrease migration and expressions of mmp9, VEGF and STAT3 in A549 cells.
机译:在这里,我们通过利用MTT和qRT-PCR研究了壳聚糖纳米颗粒对IGF-1R siRNA和阿霉素的双重递送对A549肺癌细胞株活力的影响。此外,分别通过膜联蛋白-PI和伤口愈合试验评估了处理细胞的凋亡和迁移。壳聚糖纳米粒子的尺寸约为176 nm,ζ电位和多分散指数分别约为11 mV和0.3。 IGF-1R siRNA对DOX诱导的肿瘤细胞的细胞毒性和凋亡具有协同作用。此外,负载siRNA / DOX的壳聚糖纳米颗粒可以显着降低A549细胞中mmp9,VEGF和STAT3的迁移和表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号